Ian Dettman's blog

ACMN (Australasian College of Medical Nutrition) is a not-for-profit college formed to help train doctors and Practice Nurses in Injectable Nutrition. Its formation resulted from a void in the marketplace due to a significant reduction in training in this area.

The founding fathers of injectable nutrients in Australia were Drs Glen Dettman and Archie Kalokerinos.

The Japanese College of Intravenous Therapy, headed by Dr Atsuo Yanagisawa, recently held a meeting for Doctors on the topic of “Intravenous Vitamin C and Cancer”. Several notable Japanese and o/seas researchers presented some leading edge research – included Dr Steve Hickey author of “Ascorbate –the science of Vitamin C” who was accompanied by the co-author Dr Hilary Roberts, Dr Ron Hunninghake leading researcher at the Riordan Clinic and Dr John Hoffer (Dr Abram Hoffers’s son) also a leading researcher in IVC and cancer.

The following is a link to the NZ TV program about the farmer who recovered from swine flu becuase the doctors in the hospital turned him into a prone position (and he was incidentally on high-dose IV C):

http://www.3news.co.nz/Living-Proof/tabid/371/articleID/171328/Default.aspx

This is a fascinating video, unfortuantely a typical story when families are trying to get some complementary medicines used on loved ones in hospital.

An excellent review published in 2010 in the BMJ (i) gives a current overview of the diagnosis and management of vitamin D deficiency in the UK .

Note: Where “calciferol” is mentioned the recommended form of Vitamin D is CHOLECALCIFEROL.

Overview in the UK:

A recent report AGAIN in JAMA (i) has highlighted a potential problem with very high dose oral folate along with B6 and B12 in people with diabetic nephropathy - “A multicenter, randomized, double-blind, placebo controlled trial (Diabetic Intervention with Vitamins to Improve Nephropathy [DIVINe]) at 5 university medical centers in Canada conducted between May 2001 and July 2007 of 238 participants who had type 1 or 2 diabetes and a clinical diagnosis of diabetic nephropathy.”

Patients in the trial were followed for up to 3 years AFTER the folate and B6 and B12 were stopped.

A recent report in JAMA (i) has highlighted a potential problem with very high dose oral cholecalciferol in elderly people - “A double-blind, placebo-controlled trial of 2256 community-dwelling women, aged 70 years or older, considered to be at high risk of fracture were recruited from June 2003 to June 2005 and were randomly assigned to receive cholecalciferol or placebo each autumn to winter for 3 to 5 years. The study concluded in 2008.”

The participants received a single oral dose of 500,000 IU of cholecalciferol or placebo.